Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.
GV (Google Ventures)
Activity from announced rounds
GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.
Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.
GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.
- Rounds participated in
- 42
- Confirmed lead rounds
- 2 32 roles undisclosed
- New companies
- 40 First participation on record · 2 follow-on
- Funding in participating rounds
- $24.9B 42 disclosed · full round size, not this investor’s share
By stage
1 more
By primary sector
7 more
By country
Rounds
42 in all activityOMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.
Virtual care for women with hormonal, metabolic and reproductive health needs.
Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.
Metaview provides AI agents and software for recruiters and hiring teams, from candidate sourcing and screening to interview notes and reporting.
Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.
EnduroSat designs and manufactures modular, software-defined satellites and components, and provides mission services for commercial and institutional operators.
Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.
Cloud infrastructure for validating and testing AI-generated code faster
Develops fungal genome-derived therapeutics for organ transplant rejection
Secures non-human identities and AI agents operating in third-party applications
A leading food technology platform built to make great food more accessible
Builds market infrastructure connecting space companies with sovereign buyers and capital
Builds general-purpose world models that simulate physical reality for robotics, gaming, and autonomous systems
Develops hormonal and non-hormonal male contraceptives for men and couples globally
Protects organisations from credential theft and identity-based attacks through active identity recovery technology
Offers an FDA-cleared AI-powered glucose monitoring system for weight management and metabolic health
AI-native filmmaking platform giving creators cinematic control to direct AI-generated films
Provides AI infrastructure for modern marketing
Develops self-improving AI systems that autonomously enhance their own architecture and training algorithms
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
Develops technology and services for clinical research.
Provides AI-powered estate and tax planning platform for wealth management firms
Provides Internet intelligence and insights for security operations and exposure management
Delivers AI data infrastructure for mission-critical machines across space, defense, and autonomy
Provides AI platform for healthcare finance
Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.
Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives
Enables employees to build enterprise-grade apps using natural language with secure IT integration
Provides AI agents for accountants to complete complex accounting workflows end-to-end